MedTrace Logo

Insulin- and Glucose Metabolism in Pulmonary Arterial Hypertension

NCT03584607 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2020-01-27

No results posted yet for this study

Summary

Insulin resistance is a key mechanism in metabolic disorders, which has also been implicated in the development of pulmonary hypertension. In this pilot study, the investigators´ goal is to directly determine insulin sensitivity in idiopathic pulmonary arterial hypertension patients and to compare the results with data from healthy controls.

Conditions

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Bence M. Nagy, PhD · Medical University of Graz

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-20
Primary Completion
2019-02-11
Completion
2019-02-11

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03584607 on ClinicalTrials.gov